Navigation Links
ProCertus BioPharm secures $2.3M in financing

Madison, Wis. - A Madison company that is developing drugs to protect cancer patients from common side effects of chemotherapy and radiotherapy has closed on a Series A Preferred Stock financing led by Venture Investors of Madison.

ProCertus BioPharm, an oncology-based pharmaceutical company, will ......

Full article >>> ious stages, when potential corporate partners were interested in its technology and any human data associated with it, Fahl said the new executives will be important in managing the infusion of venture capital and in identifying large pharmaceutical partners to help develop the technology and bring it to market.

Venture Investors traditionally has looked for investments in companies with......

Full article >>> five clinical studies to establish safety and efficacy for each.

Of the three drug candidates, Fahl said OralX is the only one that would face a competitive product on the market, and that particular therapy has limited efficacy.

Lab results

The inventions associated the company's intellectual property are derived from research done in Fahls laboratory. In additi......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 05/11/07


Related biology technology :

1. Glossary for The BioPharm Guide to Fermentation and Cell Culture
2. TrafficCast secures $2M from Phenomenelle Angels, NEW Capital Fund
3. Perscitus Biosciences secures $250K Commerce loan
4. Mirus Bio secures $900K grant to develop research tool
5. BioSystem Development secures angel funding
6. TrafficCast secures $1 million line of credit
7. Medical College secures $9.7M research grant
8. Wausau start up secures $560K for GPS maps
9. Platypus Technologies secures $450K SBIR grant
10. Congresswoman Baldwin secures Federal Funds for UW-Rock County
11. 2006: A great biotech financing year, unless you were going public!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... , Dec. 8, 2016  Biotheranostics today announced ... role of the Breast Cancer Index (BCI) in ... cancer are most at-risk for disease recurrence and ... results from three studies advancing the understanding of ... to tumor biology and inform decisions related to ...
(Date:12/8/2016)... USA, and CARDIFF, UK (PRWEB) , ... December ... ... with very high precision light to control cells — optogenetics — is key ... the current state of the art, spatially patterned light projected via free-space optics ...
(Date:12/8/2016)... -- Oxford Gene Technology (OGT), The ... range with the launch of the SureSeq myPanel™ NGS Custom ... in familial hypercholesterolemia (FH). The panel delivers single nucleotide variation ... small panel and allows customisation by ,mix and match, of ... LDLR , P C SK9 , ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This single ... engineered to radically streamline culture processes, minimize processing time, significantly decrease production ...
Breaking Biology Technology:
(Date:12/7/2016)... According to a new market research report "Emotion Detection ... Voice Recognition), Service, Application Area, End User, And Region - Global Forecast to ... 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a Compound ... ... MarketsandMarkets Logo ...
(Date:12/6/2016)... WARSAW, Ind. , Dec. 6, 2016  Zimmer Biomet ... that it has priced an offering of €500.0 million principal ... €500.0 million principal amount of its 2.425% senior unsecured notes ... is expected to occur on December 13, 2016, subject to the ... on an annual basis. ...
(Date:12/2/2016)... The report "Biometric Vehicle Access ... (Iris Recognition System), Vehicle Type (Passenger Car, Battery ... 2021", published by MarketsandMarkets, the market is estimated ... is projected to grow to USD 854.8 Million ...      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
Breaking Biology News(10 mins):